Finally, we explored how different biological cues could further enhance the disease state in the model and demonstrated how TGFβ could be used to create and advanced NASH disease state with enhanced fibrosis and reduced hepatic function. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.